REQUEST A DEMO
Total
USD $0.00
Search more companies

Willow Pharma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Willow Pharma S.A.S. Profile Updated: May 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Willow Pharma S.A.S. is an enterprise located in Colombia, with the main office in Medellin. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on September 20, 2013. It currently has a total number of 17 (2024) employees. There was a net sales revenue increase of 71.7% reported in Willow Pharma S.A.S.’s latest financial highlights for 2023. During that time, Willow Pharma S.A.S.’s total assets grew by 13.68%. The net profit margin of Willow Pharma S.A.S. increased by 1.08% in 2023.

Headquarters
Carrera 50 50 14, Piso 12, Edf Banco Popular
Medellin; Antioquia;

Contact Details: Purchase the Willow Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Willow Pharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Willow Pharma S.A.S. report to view the information.
Incorporation Date:
September 20, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Willow Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
71.7%
Total operating revenue
69.95%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
231.05%
Total assets
13.68%
Total equity
19.75%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
1.08%
Return on Equity (ROE)
10.52%
Debt to Equity Ratio
18.74%
Quick Ratio
0.06%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?